114 related articles for article (PubMed ID: 20673499)
41. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
42. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancer.
Hashim M; Sayed M; Samy N; Elshazly S
Med Oncol; 2011 Mar; 28(1):322-30. PubMed ID: 20146105
[TBL] [Abstract][Full Text] [Related]
44. The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer.
Huang G; Song H; Wang R; Han X; Chen L
J Surg Oncol; 2012 Mar; 105(4):420-4. PubMed ID: 21780128
[TBL] [Abstract][Full Text] [Related]
45. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
[TBL] [Abstract][Full Text] [Related]
46. Depolarized expression of episialin (EMA, MUC1) in lung adenocarcinoma is associated with tumor progression.
Guddo F; Giatromanolaki A; Patriarca C; Hilkens J; Reina C; Alfano RM; Vignola AM; Koukourakis MI; Gambacorta M; Pruneri G; Coggi G; Bonsignore G
Anticancer Res; 1998; 18(3B):1915-20. PubMed ID: 9677444
[TBL] [Abstract][Full Text] [Related]
47. Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer.
Koyi H; Brandén E; Kasim I; Wilander E
Anticancer Res; 2018 Jun; 38(6):3341-3346. PubMed ID: 29848682
[TBL] [Abstract][Full Text] [Related]
48. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
49. [Expression and clinical significance of p53 protein and p21(WAF1) in non-small-cell lung carcinoma].
Zhang H; Lü F; Yue W; Yan H; Deng L; Wang S
Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):328-30. PubMed ID: 11866928
[TBL] [Abstract][Full Text] [Related]
50. Expression of Elf-1 and survivin in non-small cell lung cancer and their relationship to intratumoral microvessel density.
Yang DX; Li NE; Ma Y; Han YC; Shi Y
Chin J Cancer; 2010 Apr; 29(4):396-402. PubMed ID: 20346215
[TBL] [Abstract][Full Text] [Related]
51. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
52. CD4+, IL17 and Foxp3 expression in different pTNM stages of operable non-small cell lung cancer and effects on disease prognosis.
Zhang GQ; Han F; Fang XZ; Ma XM
Asian Pac J Cancer Prev; 2012; 13(8):3955-60. PubMed ID: 23098499
[TBL] [Abstract][Full Text] [Related]
53. [Expression and its clinical significance of eIF4E in non-small cell lung cancer].
ZHANG B; ZHU C; CHEN B; ZHANG X; YE M; LIN A
Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1132-5. PubMed ID: 21159249
[TBL] [Abstract][Full Text] [Related]
54. CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer.
Kovaleva OV; Rashidova MA; Samoilova DV; Podlesnaya PA; Tabiev RM; Mochalnikova VV; Gratchev A
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466316
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of Derlin-1 is Associated with Poor Prognosis in Patients with Non-small Cell Lung Cancer.
Mao M; Zhang J; Jiang J
Ann Clin Lab Sci; 2018 Jan; 48(1):29-34. PubMed ID: 29530993
[TBL] [Abstract][Full Text] [Related]
56. [Expression and significance of P311 and ITGB4BP in non-small cell lung cancer].
Tang CL; Yuan SZ; Yang HP; Wang QL; Zhang R
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):526-8. PubMed ID: 21029697
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
[TBL] [Abstract][Full Text] [Related]
58. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
[TBL] [Abstract][Full Text] [Related]
59. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.
Paulsen EE; Kilvaer TK; Rakaee M; Richardsen E; Hald SM; Andersen S; Busund LT; Bremnes RM; Donnem T
Cancer Immunol Immunother; 2017 Nov; 66(11):1449-1461. PubMed ID: 28707078
[TBL] [Abstract][Full Text] [Related]
60. Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.
Zhang X; Dang Y; Li P; Rong M; Chen G
Int J Clin Exp Pathol; 2014; 7(11):8096-104. PubMed ID: 25550857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
